Ambulnz, Inc., d/b/a DocGo, a leading provider of mobile health services and integrated medical mobility solutions that has entered into an agreement to merge with Motion Acquisition Corp. (Nasdaq: MOTN), has deployed the largest no-cost co-testing program in the country with multiplex testing that now includes rapid antigen tests for flu A and flu B.

DocGo, in partnership with NYC Test & Trace Corps and NYC Health + Hospitals, made the new tests available last week across their Mobile Health fleet as well as in their dual-use and Street Health and Wellness Outreach (SHOW) units. The single-swab assays test for multiple viruses at once and provide patients with results in as little as 15 minutes.

“DocGo’s Mobile Health concept has proven uniquely valuable to facilitate a range of medical services for underserved communities across the City’s five boroughs,” said DocGo’s President Anthony Capone. “As part of our expanding health coverage for NYC, we’re proud to continue increasing the vital services we can offer to the public.”

Patients will register via DocGo’s proprietary HIPAA-compliant HealthPoint portal, healthcare providers will swab the patient, and results will be provided via digital notification after a 15-minute wait.

“I am glad we can offer these tests at the outset of the flu season, so that patients can quickly know their diagnosis and seek the resources they need,” said NYC Test & Trace Corps Executive Director Dr. Ted Long.

Each of DocGo’s Mobile Health units is deployed on a week-to-week basis and can perform up to 300 swabs per day.

Source: Company Press Release